How to apply 

Candidates will undergo a two-steps application procedure encompassing a phase of a pre-proposal submission (open to all) and a phase of full proposal submission (accessible to shortlisted applicants from the first stage).

• Submission of pre-proposals:

Each candidate must submit a max 3 A4 pages letter of intent focusing on the scientific proof of concept of the research project and attach a relevant core bibliography and short CV information.

The pre-proposal must be submitted electronically in English using the online application system no later than April 3^rd 2023 midnight, Brussels time (this is a strict deadline). A PDF version of the pre-proposal form is available here for information. This document only aims at providing an overview of the different sections. It should not be used to submit an application.

A « save and continue » module allows the applicants to quit the system and to come back working on their application at a later stage. Once the applicants quit the system, an automatic e-mail is sent to their e-mail address with a link to return to their application form.

All pre-proposals will be checked to ensure that all eligibility criteria are met before being processed to the evaluation stage.

• Submission of full proposals: 

The full proposal must be submitted electronically in English using the online application system no later than July 10^th, 2023, midnight, Brussels time (this is a strict deadline). A PDF version of the full proposal form is available here for information. This document only aims at providing an overview of the different sections. It should not be used to submit an application.

A « save and continue » module allows the applicants to quit the system and to come back working on their application at a later stage. Once the applicants quit the system, an automatic e-mail is sent to their e-mail address with a link to return to their application form.

All full proposals will be checked to ensure that all eligibility criteria are met before being processed to the evaluation stage.

• Candidates must be internationally established investigators, with outstanding scientific achievements and multiple seminal contributions in the field of rare diseases or with outstanding scientific achievements and multiple seminal contributions in common diseases, who want to focus on research in rare diseases and who can rely on a team that has the necessary competencies and expertise to carry out research in this field.
• Candidates must have a scientific seniority of min. PhD + 6 years. Scientific seniority is calculated from the PhD public defence onwards, not taking into account career breaks.
• Candidates must be affiliated to a Belgian University, a Belgian University Hospital or any of the following Research Institute:
  • Institute of Tropical Medicine Antwerp
  • LABIRIS
  • Flemish Institute for Biotechnology (VIB)
  • Flemish Institute for Technological research (VITO)
  • de Duve Institute 
  • Bordet Institute
  • GIGA Institute
  • Sciensano
  • Belgian Nuclear Research Center (SCK CEN)
• Candidates must be affiliated to their institution until December 31st, 2027.
• Candidates must not reach the retirement age limit during the project.
• In case of international collaboration, the project must be initiated and coordinated and by the team based in Belgium.

• Translational approach: referring to a research methodology integrating a basic science approach as well as clinical considerations. It encompasses all stages from bench to bedside. Beyond a better understanding of the disease, translation of the research results into benefit for the patients is a key objective of the Fund Generet. As such, a clear description of the translational strategy will be considered as a strong asset.
• Multidisciplinarity: referring to the use and application of different scientific disciplines as a substantial element of the research methodology.
• Multicentric cooperation: referring to the close collaboration with centres of excellence located in Belgium or abroad. In case of international collaboration, the researcher working in the Belgian Institution must remain the coordinator of the project.
• Communication Plan: referring to the communication about the research within the scientific community but also towards patients and a broader public (conferences, articles, video with success stories, etc.).